Department of Mechanical Systems Engineering, Tokyo University of Agriculture and Technology, Koganei, Tokyo 184-8588, Japan.
IEEE Trans Nanobioscience. 2009 Dec;8(4):349-55. doi: 10.1109/TNB.2009.2035282.
In this paper, we proposed to utilize a reconstructed cardiac tissue as microactuator with easy assembly. In a glucose solution, cardiomyocytes can contract autonomously using only chemical energy. However, a single cardiomyocyte is not enough to actuate a microrobot or a mechanical system. Though the output power will increase by using multiple cardiomyocyte, it is difficult to assemble those cardiomyocyte to predefined positions one-by-one using a micromanipulator. Reconstructed cardiac tissue not only will enable researchers to assemble the cells easily and but also has a potential to improve the contractile ability. To realize a bio-actuator in this paper, we reconstructed a microcardiac tissue using an extracellular matrix, and their displacements, displacement frequency, contractile force, and lifetime of the reconstructed cardiac tissue were evaluated. Electrical and pharmacological responses of the reconstructed cardiac tissue were also evaluated. Finally, a bioactuator, a primitive micropillar actuator, was fabricated and applicability of the reconstructed cardiac tissue for bioactuators was evaluated.
在本文中,我们提出利用重构的心脏组织作为微执行器,具有易于组装的特点。在葡萄糖溶液中,心肌细胞可以仅利用化学能自主收缩。然而,单个心肌细胞不足以驱动微机器人或机械系统。尽管使用多个心肌细胞可以增加输出功率,但使用微操作器将这些心肌细胞一一组装到预定位置是很困难的。重构的心脏组织不仅可以使研究人员更容易地组装细胞,而且还有可能提高收缩能力。为了在本文中实现生物执行器,我们使用细胞外基质构建了微心脏组织,并评估了其位移、位移频率、收缩力和重构心脏组织的寿命。还评估了重构心脏组织的电和药理反应。最后,制造了一种生物执行器,即原始微柱执行器,并评估了重构心脏组织在生物执行器中的适用性。